Identification of CYP 2A6 inhibitors in an effort to mitigate the harmful effects of the phytochemical nicotine

Abstract

Aim: In this study, our goal was to study the inhibition of nicotine metabolism by P450 2A6, as a means for reduction in tobacco use and consequently the prevention of smoking-related cancers. Nicotine, a phytochemical, is an addictive stimulant, responsible for the tobacco-dependence in smokers. Many of the other phytochemicals in tobacco, including polycyclic aromatic hydrocarbons, N-nitrosamines, and aromatic amines, are potent systemic carcinogens. Tobacco smoking causes about one of every five deaths in the United States annually. Nicotine plasma concentration is maintained by the smokers’ smoking behavior within a small range. Nicotine is metabolized by cytochrome P450s 2A6 and 2A13 to cotinine. This metabolism causes a decrease in nicotine plasma levels, which in turn leads to increased tobacco smoking, and increased exposure to the tobacco carcinogens.

Methods: Using the phytochemical nicotine as a lead structure, and taking its interactions with the P450 2A6 binding pocket into consideration, new pyridine derivatives were designed and synthesized as potential selective mechanism-based inhibitors for this enzyme.

Results: The design and synthesis of two series of novel pyridine-based compounds, with varying substituents and substitution locations on the pyridine ring, as well as their inhibitory activities on cytochrome P450 2A6 and their interactions with its active site are discussed here. Substitutions at position 3 of the pyridine ring with an imidazole or propargyl ether containing group showed the most optimal interactions with the P4502A6 active site.

Conclusion: The pyridine compounds with an imidazole or propargyl ether containing substituent on position 3 were found to be promising lead compounds for further development. Hydrogen-bonding interactions were determined to be crucial for effective binding of these molecules within the P450 2A6 active site.

Keywords

Phytochemicals / cytochrome P450 enzymes / tobacco smoking / nicotine

References

[1] Boada LD,Luzardo OP.The impact of red and processed meat consumption on cancer and other health outcomes: Epidemiological evidences.Food Chem Toxicol2016;92:236-44

[2] Lin DX,Kadlubar FF.Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rats, and mice. Drug Metab Dispos 1995;23:518-24.

[3] Wink M.Plant secondary metabolism: Diversity, function and its evolution.Natural Product Communications2008;3:1934578X0800300

[4] Ranjan A,Gupta N.Role of phytochemicals in cancer prevention.Int J Mol Sci2019;20:4981 PMCID:PMC6834187

[5] Dutta S,Saha S,Sil PC.Natural products: An upcoming therapeutic approach to cancer.Food Chem Toxicol2019;128:240-55

[6] Chapa-Oliver AM.Capsaicin: From plants to a cancer-suppressing agent.Molecules2016;21:931 PMCID:PMC6274000

[7] Venier NA,Sugar LM.Capsaicin reduces the metastatic burden in the transgenic adenocarcinoma of the mouse prostate model.Prostate2015;75:1300-11

[8] Tsai YJ.Preparation of catechin extracts and nanoemulsions from green tea leaf waste and their inhibition effect on prostate cancer cell PC-3.Int J Nanomedicine2016;11:1907-26 PMCID:PMC4866752

[9] Tu Y,Gao Y,Li B.Theaflavin-3, 3'-digallate induces apoptosis and G2 cell cycle arrest through the Akt/MDM2/p53 pathway in cisplatin-resistant ovarian cancer A2780/CP70 cells.Int J Oncol2016;48:2657-65 PMCID:PMC4863729

[10] Chen ML,Yang CM.Lycopene inhibits angiogenesis both.in vitro56:889-99

[11] Preet R,Das D.Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC.Carcinogenesis2013;34:277-86

[12] Gupta P.Inhibition of Integrin-HER2 signaling by Cucurbitacin B leads to in vitro and in vivo breast tumor growth suppression.Oncotarget2014;5:1812-28 PMCID:PMC4039119

[13] Saglam AS, Alp E, Elmazoglu Z, Menevse S. Treatment with cucurbitacin B alone and in combination with gefitinib induces cell cycle inhibition and apoptosis via EGFR and JAK/STAT pathway in human colorectal cancer cell lines.Hum Exp Toxicol2016;35:526-43

[14] Zheng Q,Liu W.Cucurbitacin B inhibits growth and induces apoptosis through the JAK2/STAT3 and MAPK pathways in SHSY5Y human neuroblastoma cells.Mol Med Rep2014;10:89-94

[15] Chen J,Zhang X,Ge B.Genistein induces apoptosis by the inactivation of the IGF-1R/p-Akt signaling pathway in MCF-7 human breast cancer cells.Food Funct2015;6:995-1000

[16] Sarkar FH.Mechanisms of cancer chemoprevention by soy isoflavone genistein.Cancer Metastasis Rev2002;21:265-80

[17] Bahrami A,Pirro M,Sahebkar A.Modulation of regulatory T cells by natural products in cancer.Cancer Lett2019;459:72-85

[18] Kim C.Anti-cancer natural products and their bioactive compounds inducing ER stress-mediated apoptosis: A Review.Nutrients2018;10:1021 PMCID:PMC6115829

[19] Kumar A.Natural products as multidrug resistance modulators in cancer.Eur J Med Chem2019;176:268-91

[20] Bonofiglio D,De Amicis F,Andò S.Natural products as promising antitumoral agents in breast cancer: Mechanisms of action and molecular targets.Mini Rev Med Chem2016;16:596-604

[21] Yin B,Zhou XL.Natural products as important tyrosine kinase inhibitors.Eur J Med Chem2019;182:111664

[22] Wink M.Evolution of secondary metabolites from an ecological and molecular phylogenetic perspective.Phytochemistry2003;64:3-19

[23] Schmeller T,Wink M.Biochemical activities of berberine, palmatine and sanguinarine mediating chemical defense against microorganisms and herbivores.Phytochemistry1997;44:257-66.

[24] Lu JJ,Chen XP,Wang YT.Alkaloids isolated from natural herbs as the anticancer agents.Evid Based Complement Alternat Med2012;2012:485042 PMCID:PMC3440018

[25] Guengerich FP.Metabolism of chemical carcinogens.Carcinogenesis2000;21:345-51

[26] He X.Role of metabolic enzymes P450 (CYP) on activating procarcinogen and their polymorphisms on the risk of cancers.Curr Drug Metab2015;16:850-63

[27] Hrycay EG.Involvement of cytochrome P450 in reactive oxygen species formation and cancer. Cytochrome P450 Function and Pharmacological Roles in Inflammation and Cancer. Elsevier; 2015. pp. 35-84.

[28] Shimada T,Gillam EM,Inoue K.Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009.Drug Metab Dispos2001;29:1176-82.

[29] Williams DE,Castagnoli N Jr.The role of cytochromes P-450 and flavin-containing monooxygenase in the metabolism of (S)-nicotine by rabbit lung.Drug Metab Dispos1990;18:418-28

[30] Bao Z,Ding X,Hong JY.Metabolism of nicotine and cotinine by human cytochrome P450 2A13.Drug Metab Dispos2005;33:258-61

[31] Peterson LA,Castagnoli N Jr.Stereochemical studies on the cytochrome P-450 catalyzed oxidation of (S)-nicotine to the (S)-nicotine delta 1'(5')-iminium species.J Med Chem1987;30:249-54

[32] Gorrod JW.The metabolism of nicotine-delta 1'(5')-iminium ion, in vivo and in vitro.Eur J Drug Metab Pharmacokinet1982;7:293-8

[33] Centers for Disease Control and Prevention - Data and Statistics, F. F. a. F. S., Smoking & Tobacco Use. https://www.cdc.gov/tobacco/data_statistics/fact_sheets/fast_facts/index.htm.

[34] Baker TB,Stein JH.Effects of nicotine patch vs Varenicline vs combination nicotine replacement therapy on smoking cessation at 26 weeks: A randomized clinical trial.JAMA2016;315:371-9 PMCID:PMC4824537

[35] National Institute on Drug Abuse. Tobacco, N., and ECigarettes, Is Nicotine Addictive? https://www.drugabuse.gov/publications/research-reports/tobacco/nicotine-addictive. [Last accessed on 1 Dec 2020]

[36] Mcmorrow MJ.Nicotine's role in smoking: An analysis of nicotine regulation.Psychological Bulletin1983;93:302-27

[37] Sellers EM,Tyndale RF.Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking.Clin Pharmacol Ther2000;68:35-43

[38] Sellers EM,Zeman MV,Tyndale RF.The effect of methoxsalen on nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism in vivo.Nicotine Tob Res2003;5:891-9

[39] Pianezza ML,Tyndale RF.Nicotine metabolism defect reduces smoking.Nature1998;393:750

[40] Rao Y,Zia M.Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking.Mol Pharmacol2000;58:747-55

[41] Ezzeldin N,Darwish A.Association of genetic polymorphisms CYP2A6*2 rs1801272 and CYP2A6*9 rs28399433 with tobacco-induced lung Cancer: case-control study in an Egyptian population.BMC Cancer2018;18:525 PMCID:PMC5934827

[42] Foroozesh M,Sridhar J.Design, synthesis, and evaluation of a family of propargyl pyridinyl ethers as potential cytochrome P450 inhibitors.J Undergrad Chem Res2013;12:91-4 PMCID:PMC4275839

[43] Shimada T,Kakimoto K.Structure-function studies of naphthalene, phenanthrene, biphenyl, and their derivatives in interaction with and oxidation by cytochromes P450 2A13 and 2A6.Chem Res Toxicol2016;29:1029-40 PMCID:PMC5293596

[44] Shimada T,Murayama N.Oxidation of pyrene, 1-hydroxypyrene, 1-nitropyrene and 1-acetylpyrene by human cytochrome P450 2A13.Xenobiotica2016;46:211-24 PMCID:PMC5270756

[45] Kramlinger VM,Murphy SE.Inhibition and inactivation of cytochrome P450 2A6 and cytochrome P450 2A13 by menthofuran, β-nicotyrine and menthol.Chem Biol Interact2012;197:87-92 PMCID:PMC3362486

[46] Prasopthum A,Sarapusit S,Rongnoparut P.Inhibition effects of Vernonia cinerea active compounds against cytochrome P450 2A6 and human monoamine oxidases, possible targets for reduction of tobacco dependence.Drug Metab Pharmacokinet2015;30:174-81

[47] Nakajima M,Yamanaka H.Isoflavones inhibit nicotine C-oxidation catalyzed by human CYP2A6.J Clin Pharmacol2006;46:337-44

[48] Gilardi G,Tsotsou GE,Fairhead M.Molecular Lego: design of molecular assemblies of P450 enzymes for nanobiotechnology.Biosensors and Bioelectronics2002;17:133-45

[49] Dodhia VR,Gilardi G.Engineering human cytochrome P450 enzymes into catalytically self-sufficient chimeras using molecular Lego.J Biol Inorg Chem2006;11:903-16

[50] Castrignanò S,Sadeghi SJ,Allegra P.Electrochemical detection of human cytochrome P450 2A6 inhibition: a step toward reducing dependence on smoking.Anal Chem2014;86:2760-6

[51] Denton TT,Xia Z.Identification of the 4-position of 3-alkynyl and 3-heteroaromatic substituted pyridine methanamines as a key modification site eliciting increased potency and enhanced selectivity for cytochrome P-450 2A6 inhibition.J Med Chem2018;61:7065-86 PMCID:PMC6309628

[52] Denton TT,Cashman JR.Nicotine-related alkaloids and metabolites as inhibitors of human cytochrome P-450 2A6.Biochem Pharmacol2004;67:751-6

[53] Denton TT,Cashman JR.5-substituted, 6-substituted, and unsubstituted 3-heteroaromatic pyridine analogues of nicotine as selective inhibitors of cytochrome P-450 2A6.J Med Chem2005;48:224-39

[54] Yano JK,Cerny MA,Johnson EF.Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.J Med Chem2006;49:6987-7001

[55] Liu J,Dupart PS.Pyranoflavones: a group of small-molecule probes for exploring the active site cavities of cytochrome P450 enzymes 1A1, 1A2, and 1B1.J Med Chem2013;56:4082-92 PMCID:PMC3685175

[56] Sridhar J,Liu J,Stevens CL.In silico studies of polyaromatic hydrocarbon inhibitors of cytochrome P450 enzymes 1A1, 1A2, 2A6, and 2B1.Chem Res Toxicol2010;23:600-7 PMCID:PMC2839030

[57] Sridhar J,Komati R.Ortho-methylarylamines as time-dependent inhibitors of cytochrome P450 1A1 enzyme.Drug Metab Lett2017;10:270-7 PMCID:PMC6697106

[58] DeVore NM.Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone binding and access channel in human cytochrome P450 2A6 and 2A13 enzymes.J Biol Chem2012;287:26576-85 PMCID:PMC3410998

[59] Mao W,Schuler MA.Modifications in the N-terminus of an insect cytochrome P450 enhance production of catalytically active protein in baculovirus-Sf9 cell expression systems.Insect Biochem Mol Biol2008;38:66-75 PMCID:PMC2204081

[60] Schwarz D,Honeck H,Schunck WH.Co-expression of human cytochrome P4501A1 (CYP1A1) variants and human NADPH-cytochrome P450 reductase in the baculovirus/insect cell system.Xenobiotica2001;31:345-56

[61] Grogan J,Andrusiak EA.Cytochrome P450 2A1, 2E1, and 2C9 cDNA-expression by insect cells and partial purification using hydrophobic chromatography.Biochemical Pharmacology1995;50:1509-15